STABILITY STUDIES OF SOME NEW POLYHERBAL TABLET FORMULATIONS FOR THE TREATMENT OF DIABETES AND HYPERLIPIDEMIA Authors: Raju P , PRANITHA B, SRINIVAS N, SAMREEN B, VIVEK SAGAR P AND SIRISHA K*
ABSTRACT
This study involved formulating five different polyherbal tablets (F1 to F5) using three
standardized extracts: Momordica charantia (which contains 3% bitter principle),
Cinnamomum cassia (10% total phenols), and Stevia rebaudiana. The tablets used wet
granulation with microcrystalline cellulose (MCC PH101) as a diluent, Povidone K30 as a
binder, and magnesium stearate and talc as glidants. To evaluate the tablets, methylparaben
(0.1% to 0.2%) and propylparaben (0.1% to 0.25%) were used to create different tablet
compositions (F2 to F5). The tablets were then tested for precompression parameters (angle of
repose, bulk density, tapped density, and compressibility index) and post-compression
parameters (weight variation test, friability test, hardness test, and stability studies). All
formulations (F1 to F5) met the required specifications and were found to be stable for up to
90 days. The tablets containing propylparaben (F4&F5) were harder and less friable than those
containing methylparaben (F2&F3), indicating better dissolution. The concentration of
preservatives affected the tablets.
Keywords: Polyherbal, Momordica, Cinnamon, Stevia, Formulations Publication date: 01/05/2026 https://www.ijbpas.com/pdf/2026/May/MS_IJBPAS_2026_10174.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2026/15.5.10174